MoneyWorks4Me

With no major difference for the quarter endedSeptember 2021 , the total revenue stood at Rs. 2299.24  millions.Net Profit witnessed a 158.60% growth almost the double from Rs. 92.24 millions to Rs. 238.53  millions  of same quarter last year.Operating Profit saw a handsome growth to 619.19 millions from 540.25 millions in the quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 2299.24 2211.99 3.94 4719.74 4250.54 11.04 8565.78 7518.37 13.93
Other Income 71.46 57.94 23.33 130.96 117.22 11.72 231.28 360.20 -35.79
PBIDT 619.19 540.25 14.61 1189.27 1029.21 15.55 2036.24 1779.80 14.41
Interest 241.92 249.56 -3.06 483.13 499.99 -3.37 1002.16 1074.82 -6.76
PBDT 377.27 290.69 29.78 706.14 529.22 33.43 1034.08 704.98 46.68
Depreciation 138.74 198.45 -30.09 279.31 395.30 -29.34 872.92 900.59 -3.07
PBT 238.53 92.24 158.60 426.83 133.92 218.72 161.16 -195.61 -182.39
TAX 0.00 0.00 0.00 0.78 0.00 0.00 205.16 12.26 1573.41
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 94.76 8.22 1052.80
PAT 238.53 92.24 158.60 426.05 133.92 218.14 -44.00 -207.87 -78.83
Equity 590.87 590.87 0.00 590.87 590.87 0.00 590.87 590.87 0.00
PBIDTM(%) 26.93 24.42 10.26 25.20 24.21 4.06 23.77 23.67 0.42
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..